These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 8353889)

  • 1. Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction.
    Liu Y; Thornton JD; Cohen MV; Downey JM; Schaffer SW
    Circulation; 1993 Sep; 88(3):1273-8. PubMed ID: 8353889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetylcysteine Protects Against Myocardial Ischemia-Reperfusion Injury Through Anti-ferroptosis in Type 1 Diabetic Mice.
    Zhou D; Yang Y; Chen J; Zhou J; He J; Liu D; Zhang A; Yuan B; Jiang Y; Xia W; Han R; Xia Z
    Cardiovasc Toxicol; 2024 May; 24(5):481-498. PubMed ID: 38647950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chrysin restores the cardioprotective effect of ischemic preconditioning in diabetes-challenged rat heart.
    Singh G; Varshney V; Goyal A; Ali N; Iqbal M; Kaur I; Vargas-De-La-Cruz C; Behl T
    Heliyon; 2023 Nov; 9(11):e22052. PubMed ID: 38027733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart Failure And Type 2 Diabetes Mellitus: Neurohumoral, Histological And Molecular Interconnections.
    Ushakov A; Ivanchenko V; Gagarina A
    Curr Cardiol Rev; 2023; 19(2):e170622206132. PubMed ID: 35718961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Contribution of Cardiac Fatty Acid Oxidation to Diabetic Cardiomyopathy Severity.
    Karwi QG; Sun Q; Lopaschuk GD
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic inhibition of phosphodiesterase 5 with tadalafil affords cardioprotection in a mouse model of metabolic syndrome: role of nitric oxide.
    Koka S; Xi L; Kukreja RC
    Mol Cell Biochem; 2020 May; 468(1-2):47-58. PubMed ID: 32162053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of O-GlcNAcylation for Protection against Ischemia-Reperfusion Injury.
    Jensen RV; Andreadou I; Hausenloy DJ; Bøtker HE
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperoxia-induced cardiotoxicity and ventricular remodeling in type-II diabetes mice.
    Rodgers JL; Samal E; Mohapatra S; Panguluri SK
    Heart Vessels; 2018 May; 33(5):561-572. PubMed ID: 29209776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection.
    Russell J; Du Toit EF; Peart JN; Patel HH; Headrick JP
    Cardiovasc Diabetol; 2017 Dec; 16(1):155. PubMed ID: 29202762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-linear actions of physiological agents: Finite disarrangements elicit fitness benefits.
    Sedlic F; Kovac Z
    Redox Biol; 2017 Oct; 13():235-243. PubMed ID: 28595161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemic preconditioning: Interruption of various disorders.
    Goyal A; Agrawal N
    J Saudi Heart Assoc; 2017 Apr; 29(2):116-127. PubMed ID: 28373786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term consumption of an obesogenic high fat diet prior to ischemia-reperfusion mediates cardioprotection via Epac1-dependent signaling.
    Edland F; Wergeland A; Kopperud R; Åsrud KS; Hoivik EA; Witsø SL; Æsøy R; Madsen L; Kristiansen K; Bakke M; Døskeland SO; Jonassen AK
    Nutr Metab (Lond); 2016; 13():87. PubMed ID: 27933093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Influence of Diabetes Mellitus in Myocardial Ischemic Preconditioning.
    Rezende PC; Rahmi RM; Hueb W
    J Diabetes Res; 2016; 2016():8963403. PubMed ID: 27656659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental Diabetes Mellitus in Different Animal Models.
    Al-Awar A; Kupai K; Veszelka M; Szűcs G; Attieh Z; Murlasits Z; Török S; Pósa A; Varga C
    J Diabetes Res; 2016; 2016():9051426. PubMed ID: 27595114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Modification of Mitochondrial ROS Production Converts High Glucose-Induced Cytotoxicity to Cytoprotection: Effects on Anesthetic Preconditioning.
    Sedlic F; Muravyeva MY; Sepac A; Sedlic M; Williams AM; Yang M; Bai X; Bosnjak ZJ
    J Cell Physiol; 2017 Jan; 232(1):216-24. PubMed ID: 27138089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 diabetes mellitus and myocardial ischemic preconditioning in symptomatic coronary artery disease patients.
    Rezende PC; Rahmi RM; Uchida AH; da Costa LM; Scudeler TL; Garzillo CL; Lima EG; Segre CA; Girardi P; Takiuti M; Silva MF; Hueb W; Ramires JA; Kalil Filho R
    Cardiovasc Diabetol; 2015 May; 14():66. PubMed ID: 26025451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemic conditioning: the challenge of protecting the diabetic heart.
    Wider J; Przyklenk K
    Cardiovasc Diagn Ther; 2014 Oct; 4(5):383-96. PubMed ID: 25414825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High carbohydrate and high fat diets protect the heart against ischaemia/reperfusion injury.
    Salie R; Huisamen B; Lochner A
    Cardiovasc Diabetol; 2014 Jul; 13():109. PubMed ID: 25197961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bitter fate of the sweet heart: impairment of iron homeostasis in diabetic heart leads to failure in myocardial protection by preconditioning.
    Vinokur V; Berenshtein E; Bulvik B; Grinberg L; Eliashar R; Chevion M
    PLoS One; 2013; 8(5):e62948. PubMed ID: 23690966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning.
    Miki T; Itoh T; Sunaga D; Miura T
    Cardiovasc Diabetol; 2012 Jun; 11():67. PubMed ID: 22694800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.